stockrowDr. Reddy's Laboratories Ltd (RDY) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Dr. Reddy's Laboratories Ltd RDY 14.74 +1.45%
- Teva Pharmaceutical Industries Ltd. TEVA 42.33 +1.32%
Dr. Reddy's Laboratories Ltd and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $48.7B against $12.1B — 4.0× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 44.4× against 92.6×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 2.71% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs 2.94%) and the higher return on invested capital (4.77% vs 4.09%). Across the 22 metrics below, Dr. Reddy's Laboratories Ltd leads on 13 and Teva Pharmaceutical Industries Ltd. on 9.
Valuation
Profitability
| Metric | RDY | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 53.51% | 53.51% |
| Operating margin | 9.20% | 7.84% | 0.00% |
| Net margin | 8.06% | 2.94% | (2.45%) |
| Free cash flow margin | 2.88% | 7.71% | 0.00% |
| Return on equity | 6.60% | 6.65% | (0.80%) |
| Return on assets | 4.44% | 1.27% | (1.67%) |
| Return on invested capital | 4.77% | 4.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack